Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Kinetics of Chimerism and Unit Predominance After Double Umbilical Cord Blood Transplantation

Pablo A. Ramirez, MD, John E. Wagner, MD, Todd Defor, MS, Bruce R. Blazar, MD, Michael Verneris, MD, Jeffrey S. Miller, MD, Daniel J. Weisdorf, MD, Phillip McGlave, MD, Claudio Brunstein, MD

Blood (2010) 116 (21): 225.

https://doi.org/10.1182/blood.V116.21.225.225

Published: 2010

Journal Articles

Comparison of Two Mycophenolate Mofetil Dosing Regimens Following Hematopoietic Cell Transplantation (HCT).

Pamala A. Jacobson, PharmD, Sheiren Farag El-Massah, John Rogosheske, PharmD, Amber Kerr, RN, Janel Boyle-Long, PharmD, Todd DeFor, MS, Cathryn Jennisen, PharmD, Claudio Brunstein, MD, John E. Wagner, MD, Marcie Tomblyn, MD, Daniel Weisdorf, MD

Blood (2008) 112 (11): 1116.

https://doi.org/10.1182/blood.V112.11.1116.1116

Published: 2008

Journal Articles

Alternate Donor HCT for Fanconi Anemia (FA): Results of a Total Body Irradiation (TBI) Dose De-Escalation Study

Margaret L. MacMillan, MD, Bruce R. Blazar, MD, Todd DeFor, MS, Linan Ma, MSPH, Jakub Tolar, MD, Heather Zierhut, MS, John E. Wagner, MD

Blood (2008) 112 (11): 2998.

https://doi.org/10.1182/blood.V112.11.2998.2998

Published: 2008

Journal Articles

Higher Mycophenolate Dose Requirements in Children Undergoing Hematopoietic Cell Transplant (HCT).

Pamala A. Jacobson, PharmD, Jiayin Huang, MS, Nancy Rydholm, PharmD, MyHang Tran, PharmD, Todd DeFor, MS, Jakub Tolar, MD, PhD, Paul J. Orchard, MD

Blood (2007) 110 (11): 3011.

https://doi.org/10.1182/blood.V110.11.3011.3011

Published: 2007

Journal Articles

Double Umbilical Cord Blood Transplant Patients Have a Higher Risk of HHV-6 Infection.

Sharon F. Chen, MD, Todd DeFor, MS, Avis J. Thomas, MS, K. Scott Baker, MD, MS

Blood (2006) 108 (11): 5305.

https://doi.org/10.1182/blood.V108.11.5305.5305

Published: 2006

Journal Articles

Promising Progression Free and Overall Survival Using a Novel (CY/FLU/TBI) Reduced-Intensity Conditioning (RIC) Regimen for Allogeneic Sibling Stem Cell Transplantation (SCT).

Marcie Tomblyn, MD, MS, Jeffrey S. Miller, MD, Linda J. Burns, MD, Bruce R. Blazar, MD, PhD, Mukta Arora, MD, MS, Xianghua Luo, PhD, Todd Defor, MS, Claudio Brunstein, MD, PhD, Kathryn Dusenbery, MD, Margaret L. MacMillan, MD, Michael Verneris, MD, PhD, John Wagner, MD, Daniel J. Weisdorf, MD

Blood (2006) 108 (11): 2999.

https://doi.org/10.1182/blood.V108.11.2999.2999

Published: 2006

Journal Articles

Umbilical Cord Blood Transplantation (UCBT) at the University of Minnesota: Impact of Double Unit and Fludarabine on Engraftment after Myeloablative Conditioning.

Claudio G. Brunstein, MD, PhD, Todd Defor, MS, John E. Wagner, MD

Blood (2006) 108 (11): 3116.

https://doi.org/10.1182/blood.V108.11.3116.3116

Published: 2006

Journal Articles

Umbilical Cord Blood Transplant after Reduced Intensity Conditioning Provides Outcomes Comparable HLA-Matched Siblings for Patients with High Risk and Advanced Acute Myeloid Leukemia.

Claudio G. Brunstein, MD, PhD, Daniela Setubal, MD, Marcie Tomblyn, MD, Todd DeFor, MS, Mukta Arora, MD, Linda J. Burns, MD, Jeffrey S. Miller, MD, Daniel J. Weisdorf, MD, John E. Wagner, MD

Blood (2006) 108 (11): 606.

https://doi.org/10.1182/blood.V108.11.606.606

Published: 2006

Journal Articles

Increased Risk of Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disorder (EBV-PTLD) after Anti-Thymocyte Globulin (ATG) Non-Myeloablative (NMA) Conditioning for Umbilical Cord Blood Transplantation (UCBT).

Claudio G. Brunstein, MD, PhD, Daniel J. Weisdorf, MD, Todd DeFor, MS, Jakub Tolar, MD, PhD, John E. Wagner, MD

Blood (2005) 106 (11): 3235.

https://doi.org/10.1182/blood.V106.11.3235.3235

Published: 2005

Journal Articles

Oral Bioavailability of Mycophenolate Mofetil in Patients Undergoing Nonmyeloablative Hematopoietic Cell Transplantation (HCT) Is Poor and Highly Variable.

Pamala Jacobson, PharmD, Green Kathleen, PharmD, John Rogosheske, PharmD, Claudio Brunstein, MD, Juliet Barker, MBBS, Todd DeFor, MS, Philip McGlave, MD, Daniel Weisdorf, MD

Blood (2005) 106 (11): 842.

https://doi.org/10.1182/blood.V106.11.842.842

Published: 2005

Journal Articles

Prolonged Remissions with Autologous and Allogeneic Stem Cell Transplantation for Burkitt’s Lymphoma: Long Term Follow-Up at a Single Institution.

Purvi Gada, MBBS, Todd Defor, MS, Daniel J. Weisdorf, MD, Jeffrey S. Miller, MD, Paul J. Orchard, MD, Margaret L. MacMillan, MD, Mukta Arora, MD, Marcie Tomblyn, MD, Linda J. Burns, MD

Blood (2005) 106 (11): 1133.

https://doi.org/10.1182/blood.V106.11.1133.1133

Published: 2005

NARROW

Kinetics of Chimerism and Unit Predominance After Double Umbilical Cord Blood Transplantation

Comparison of Two Mycophenolate Mofetil Dosing Regimens Following Hematopoietic Cell Transplantation (HCT).

Alternate Donor HCT for Fanconi Anemia (FA): Results of a Total Body Irradiation (TBI) Dose De-Escalation Study

Higher Mycophenolate Dose Requirements in Children Undergoing Hematopoietic Cell Transplant (HCT).

Double Umbilical Cord Blood Transplant Patients Have a Higher Risk of HHV-6 Infection.

Promising Progression Free and Overall Survival Using a Novel (CY/FLU/TBI) Reduced-Intensity Conditioning (RIC) Regimen for Allogeneic Sibling Stem Cell Transplantation (SCT).

Umbilical Cord Blood Transplantation (UCBT) at the University of Minnesota: Impact of Double Unit and Fludarabine on Engraftment after Myeloablative Conditioning.

Umbilical Cord Blood Transplant after Reduced Intensity Conditioning Provides Outcomes Comparable HLA-Matched Siblings for Patients with High Risk and Advanced Acute Myeloid Leukemia.

Increased Risk of Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disorder (EBV-PTLD) after Anti-Thymocyte Globulin (ATG) Non-Myeloablative (NMA) Conditioning for Umbilical Cord Blood Transplantation (UCBT).

Oral Bioavailability of Mycophenolate Mofetil in Patients Undergoing Nonmyeloablative Hematopoietic Cell Transplantation (HCT) Is Poor and Highly Variable.

Prolonged Remissions with Autologous and Allogeneic Stem Cell Transplantation for Burkitt’s Lymphoma: Long Term Follow-Up at a Single Institution.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only